남희철 (가톨릭대학교 의과대학)님 | 한빛사연구자 > 한빛사

가톨릭대학교 의과대학

CV File

응용의학

최종업데이트 2024.12.06.

Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma
- Radiology, Aug 2026, 320 (2) | https://doi.org/10.1148/radiol.253280
- 2026-08
- 의약학
- 한빛사논문
[Correspondence] Letter to the Editor: Are we overestimating LSM-based HCC risk in MASLD? Addressing immortal time bias
- Hepatology, Oct 06 2025, | https://doi.org/10.1097/HEP.0000000000001562
- 2025-10
- 의약학
- 한빛사논문
[Correspondence] Reply: The CRAPT-M score: Robust enough for clinical practice?
- Hepatology, Aug 14 2025, | https://doi.org/10.1097/HEP.0000000000001488
- 2025-08
- 의약학
- 한빛사논문
Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumab
- Hepatology, Jun 30 2025, | https://doi.org/10.1097/HEP.0000000000001444
- 2025-06
- 의약학
- 한빛사논문
Incorporating ALBI Grade with Geriatric Nutritional Risk Index Enhances Hepatocellular Carcinoma Risk Stratification
- Liver Cancer, October 05 2024 | https://doi.org/10.1159/000541647
- 2024-10
- 의약학
- 한빛사논문
Analysis of Immune-Related Adverse Events of Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma: A Multicenter Cohort Study
- Liver Cancer, DECEMBER 21 2023 | https://doi.org/10.1159/000535839
- 2023-12
- 의약학
- 한빛사논문
Prediction of Hepatocellular Carcinoma by On-Therapy Response of Noninvasive Fibrosis Markers in Chronic Hepatitis B
- Am. J. Gastroenterol., March 10, 2021 - Volume Publish Ahead of Print - Issue | 10.14309/ajg.0000000000001219
- 2021-03
- 의약학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기